Table 7: Mean Changes in Anthropometry and Cardiometabolic Parameters After 36-Week Open-Label Treatment Followed by Randomized Withdrawal (Study 4) in Patients with Obesity or Overweight Obstructive Sleep Apnea Studies in Adults with Obesity Overview of Study 5 and Study 6 The efficacy of ZEPBOUND for moderate to severe obstructive sleep apnea (OSA) (apnea-hypopnea index [AHI] 15) in patients with obesity (BMI 30 kg/m2) was evaluated in a master protocol clinical trial (NCT05412004) that included two randomized, double-blind, placebo-controlled trials (Study 5 and Study 6) of 52 weeks duration
PlexusDx semaglutide therapy, at $189/mo month-to-month, or from $149/mo on the 6-month plan, helps patients achieve these clinically significant reductions
The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across those variants
Heilbrunn ES, Ssentongo P, Chinchilli VM, Oh J, Ssentongo AE
If you take Ozempic for diabetes, youll likely experience changes in your blood sugar levels over the next three months after stopping the medication